Do you continue biologics in sJIA patients who develop lung disease on anti IL-1 or anti IL-6 therapies?
This question is part of our collaboration with ACR Convergence 2024 to Continue the Conversation from the meeting. This question was inspired by the session "Pediatric Great Debate – To treat or not to treat SJIA lung disease with biologics" by Dr. @Dr. First Last and Dr. @Dr. First Last.
Community PollStarted
Do you continue biologics in sJIA patients who develop lung disease on anti IL-1 or anti IL-6 therapies?
12 physicians have voted
Join Mednetto vote and see how they answered.
2 Answers
Mednet Member
Rheumatology · Weill Cornell Medical College of Cornell University
Answered on
It really does depend. If a child is otherwise doing well, stopping cytokine inhibitors can worsen the underlying disease precipitously, putting the child at risk. More often than not, in my experience, at the time that lung disease is discovered, the treatments are not controlling the underlying di...
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Rheumatology · University of Alabama Birmingham
Answered on
As was mentioned in the debate, "it depends." I also exclusively use weekly SC methotrexate and anakinra to treat sJIA. I likely would not stop anakinra unless there was a clear allergic reaction to the injections. If MAS is an issue, as it often is with sJIA lung disease, then all the more reason t...
Join for free or sign in to see the full answer